Abstract:Background Stimulator of interferon genes (STING) is an innate immune sensor of cytoplasmic double-stranded DNA originating from microorganisms and host cells. The activation of cytosolic DNA-STING pathway in tumor microenvironments is usually linked to more robust adaptive immune responses to tumors, however the intracellular function of STING in regulatory T cells is largely unknown. In the present study, we aimed to explore the contribution of intracellular STING activation to regulatory T cell induction (iTreg) in cervical cancer (CC) microenvironments. Methods Blood samples and tumor specimens were obtained from patients with CC. The intratumoral STING, CCL22, CD8 and forkhead box P3 (FOXP3) expression levels were measured by immunohistochemistry. T cell-specific STING conditional knockout mice (CD4-Cre/STING(flox/flox), TKO) were generated, and syngeneic TC-1 tumor model were investigated. The differentiation and molecular regulatory pathway of human and murine iTreg under different treatments were investigated by ex vivo assays, immunoblotting and quantitative PCR. Tumor-associated exosomes (T-EXO) were isolated from CC cell lines and exosomal contents were identified by ELISA and Western blot analysis. The impact of T-EXO on T cell differentiation was tested in in vitro cell culture. Results Increased STING, CCL22 level, FOXP3(+) cells but decreased CD8(+) cells in tumor tissues predicted poor survival. Tumor-bearing CD4-Cre-STING(flox/flox) (TKO) mice displayed slower tumor growth tendencies as well as fewer FOXP3(+) cells but higher CD8(+) cell proportion in tumor tissues than wild-type (WT) mice. Activating of STING signaling cooperated with T cell receptor, interleukin-2 receptor and transforming growth factor-beta (TGF-beta) signals to promote CD4(+)CD25(high)FOXP3(+) iTreg differentiation from both human and murine CD4(+)-naive T cells from WT and IFNAR(-/-) mice but not TKO or IRF3(-/-) mice in vitro. Ectopic STING, TBK1 or IRF3 expression promoted iTreg differentiation from human CD4(+)-naive T cells. T cell-intrinsic STING activation induced FOXP3 transcription through TBK1-IRF3-mediated SMAD3 and STAT5 phosphorylation independent of interferon-beta. In CC, tumor-derived exosomes activated STING signaling in tumor-infiltrated T cells by exosomal TGF-beta, cyclic GMP-AMP synthase and 2'-3'-cGAMP, leading to iTreg expansion. Conclusions These findings highlight a novel mechanism for iTreg expansion mediated by tumor-derived exosome-activated T cell-intrinsic STING signal, and provide a rationale for developing immunotherapeutic strategies targeting STING signal in CC.

STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion

STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity

T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

STING agonists drive recruitment and intrinsic type I interferon responses in monocytic lineage cells for optimal anti-tumor immunity

Abstract LB114: STING licensing of type I dendritic cells potentiates antitumor immunity

STING Signaling in Tumorigenesis and Cancer Therapy: A Friend or Foe?

STING-mediated DNA sensing in cancer immunotherapy

Synthetic Enforcement of STING Signaling in Cancer Cells Appropriates the Immune Microenvironment for Checkpoint Inhibitor Therapy.

STAT3 Inhibition Enhances CDN-induced STING Signaling and Antitumor Immunity

cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors

Advances in the Prerequisite and Consequence of STING Downstream Signalosomes

Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy

Systemic Administration of STING Agonist Promotes Myeloid Cells Maturation and Antitumor Immunity Through Regulating Hematopoietic Stem and Progenitor Cell Fate

STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity

Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy

The miRNA-185-5p/STIM1 Axis Regulates the Invasiveness of Nasopharyngeal Carcinoma Cell Lines by Modulating EGFR Activation-Stimulated Switch from E- to N-Cadherin

STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade

Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy

STING signaling promotes NK cell antitumor immunity and maintains a reservoir of TCF-1+ NK cells

STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2